Analyst Ratings for Halozyme Therapeutics (HALO)
HALO Rating Summary
HALO Price Target Summary
- Highest: $66.00 (JMP Securities)
- Lowest: $42.00 (Leerink Partners)
- Average: $53.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$53.20 (+34%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
Avg. $ Target:
$53.20 (+34%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/24/2023 | H.C. Wainwright » Updated 10/19/2023 |
Mitchell Kapoor | New Coverage | Buy (N/A) |
61.00 (60.00) |
42.89 (39.69) |
-7.46% | Details |
| 7/24/2023 | Goldman Sachs » Updated 10/16/2023 |
Corinne Jenkins | Downgrade | Neutral (Buy) |
44.00 (N/A) |
42.57 (39.69) |
-6.77% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
